Format
Sort by

Send to:

Choose Destination

Results: 3

1.

Polypharmacy in patients hospitalised for acute exacerbation of COPD.

Díez-Manglano J, Barquero-Romero J, Mena PA, Recio-Iglesias J, Cabrera-Aguilar J, López-García F, Viu RB, Soriano JB; ECCO Study Researchers.

Eur Respir J. 2014 Sep;44(3):791-4. doi: 10.1183/09031936.00014814. Epub 2014 May 15. No abstract available.

PMID:
24833769
2.

Comorbidities and short-term prognosis in patients hospitalized for acute exacerbation of COPD: the EPOC en Servicios de medicina interna (ESMI) study.

Almagro P, Cabrera FJ, Diez J, Boixeda R, Alonso Ortiz MB, Murio C, Soriano JB; Working Group on COPD , Spanish Society of Internal Medicine.

Chest. 2012 Nov;142(5):1126-33. doi: 10.1378/chest.11-2413.

PMID:
23303399
3.

[How beta-blockers are used in Spain? Analysis of limitations in their use in internal medicine and cardiology: CARACTER-BETA study].

Garcia-Moll X, Fácila L, Conthe P, Zapata A, Artigas R, Bertomeu V, González-Juanatey JR; investigadores del estudio CARACTER-BETA.

Rev Esp Cardiol. 2011 Oct;64(10):883-90. doi: 10.1016/j.recesp.2011.05.023. Epub 2011 Aug 31. Spanish.

Format
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk